Last month, India and South Africa led several countries in calling for patents and other intellectual properties related to COVID-19 to be waived during the pandemic. While the movement has gained traction through recent talks, many notable countries have said “no”. So is such a waiver necessary or important to better tackle the pandemic?

Image Source: Shutterstock 

Produced by: Lim Sue Ann

Presented by: Juliet Jacobs, Lim Sue Ann, Dashran Yohan

Download the BFM mobile app. Stay at home and stay up-to-date.

Tags:  The Bigger Picture,  The Daily Digest,  COVID-19,  Vaccine,  Intellectual Property,  Patent,  Waiver,  World Trade Organisation,  World Intellectual Property Organisation (WIPO),  Trade-Related Aspects of Intellectual Property Rights (TRIPS Agreement),  COVAX,  Médecins Sans Frontières,  Doctors Without Borders,  Pharmaceutical Companies,  Healthcare, Pharma, Biotech,  Other personality interviews,  Politics, News, Current Affairs,  Health,  Health Policy,  Diseases and Conditions,  Mental Health,  Healthy Living,  Fitness,  Science,  Politics,  Social Issues,  Medical Innovation and Technology